Zura Bio Ltd
Zura Bio Ltd (ZURA): 5 pipeline candidates · ~36 mo cash runway · 3 clinical trials. Updated within the last hour.
BioSniper Score
5-factor signal · derived from public data
35.8 months
18% dilution
Lead: Phase 2
5 candidates
N/A
1 buy · 0 sells (180d)
A transparent, data-derived signal for Zura Bio Ltdacross cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$349.2M
Cash
$225.6M
Quarterly Burn
$18.9M
Runway
35.8 mo
Revenue
—
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (5 candidates)
| Drug | Phase |
|---|---|
| crebankitug | Preclinical |
| tibulizumab | Phase 2 |
| tibulizumab dose a | Phase 2 |
| tibulizumab dose b | Phase 2 |
| torudokimab | Preclinical |
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
89
Total value held
$296.5M
| Holder | Shares | Value |
|---|---|---|
| suvretta capital management, llc | 9,067,001 | $53.9M |
| great point partners llc | 4,215,930 | $25.1M |
| braidwell lp | 3,988,989 | $23.7M |
| commodore capital lp | 3,250,000 | $19.3M |
| adage capital partners gp, l.l.c. | 2,750,000 | $16.4M |
| affinity asset advisors, llc | 2,564,303 | $15.3M |
| millennium management llc | 1,508,063 | $9.0M |
| stempoint capital lp | 1,507,040 | $9.0M |
| armistice capital, llc | 1,507,000 | $9.0M |
| cormorant asset management, lp | 1,450,000 | $8.6M |
Showing top 10 of 89 institutional holders of Zura Bio Ltd. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in Zura Bio Ltd's pipeline?
Zura Bio Ltd (ZURA) has 5 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is Zura Bio Ltd's lead drug candidate?
Zura Bio Ltd's most advanced tracked candidate is crebankitug (Preclinical) for Autoimmune diseases where IL-7 or TSLP signaling has been implicated.
What is Zura Bio Ltd's cash runway?
Based on its most recent reported cash balance and quarterly burn rate, Zura Bio Ltd has approximately 35.8 months of cash runway.
What is Zura Bio Ltd's market capitalization?
Zura Bio Ltd's market capitalization is approximately $349.2M.
Who is the CEO of Zura Bio Ltd?
Dr. Sandeep Chidambar Kulkarni M.D. is the chief executive officer of Zura Bio Ltd (ZURA).
Get the full picture on Zura Bio Ltd
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.